Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.55 is 12% below its 5-year average of 2.88, near the low end of its 5-year range (1.88–7.25).
As of the fiscal period ended Tuesday, June 30, 2026. 18.85% above its 12-month average of 2.15.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.55.
QUICK RATIO (ACID-TEST)
2.55
QUICK RATIO (ACID-TEST) AVG TTM
2.15
QUICK RATIO (ACID-TEST) AVG 3Y
2.61
QUICK RATIO (ACID-TEST) AVG 5Y
2.88
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+18.85%
CURRENT VS 3Y AVG
-2.25%
CURRENT VS 5Y AVG
-11.56%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 609 covered companies
CURRENT VS SECTOR MEDIAN
-14.70%
vs the sector median at left
Market Cap
$1.50B
Quick Ratio (Acid-Test)
1.30
TTM Avg
1.23
3Y Avg
1.77
5Y Avg
3.05
Market Cap
$1.47B
Quick Ratio (Acid-Test)
28.70
TTM Avg
25.68
3Y Avg
28.23
5Y Avg
39.61
Market Cap
$1.46B
Quick Ratio (Acid-Test)
2.94
TTM Avg
3.04
3Y Avg
2.84
5Y Avg
2.90
Market Cap
$1.53B
Quick Ratio (Acid-Test)
4.96
TTM Avg
2.73
3Y Avg
2.17
5Y Avg
2.82
Market Cap
$1.44B
Quick Ratio (Acid-Test)
18.31
TTM Avg
12.63
3Y Avg
8.12
5Y Avg
8.12
Market Cap
$1.53B
Quick Ratio (Acid-Test)
15.18
TTM Avg
8.03
3Y Avg
6.72
5Y Avg
22.81
Market Cap
$1.43B
Quick Ratio (Acid-Test)
5.61
TTM Avg
9.29
3Y Avg
11.65
5Y Avg
16.84
Market Cap
$1.43B
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Certara, Inc. (CERT) | $1.49B | 2.55 | 2.15 | 2.61 | 2.88 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 1.30 | 1.23 | 1.77 | 3.05 |
| GH Research PLC (GHRS)vs › | $1.47B | 28.70 | 25.68 | 28.23 | 39.61 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 2.94 | 3.04 | 2.84 | 2.90 |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 4.96 | 2.73 | 2.17 | 2.82 |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.44B | 18.31 | 12.63 | 8.12 | 8.12 |
| Innoviva, Inc. (INVA)vs › | $1.53B | 15.18 | 8.03 | 6.72 | 22.81 |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 5.61 | 9.29 | 11.65 | 16.84 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.43B | N/A | N/A | N/A | N/A |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.38B | 5.07 | 3.94 | 5.82 | 6.31 |
Quick Ratio
2.55
Excludes inventory
Current Ratio
2.55
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.55 |
| 2026-03-31 | 1.88 |
| 2025-12-31 | 2.05 |
| 2025-09-30 | 2.09 |
| 2025-06-30 | 2.16 |
| 2025-03-31 | 2.78 |
| 2024-12-31 | 2.13 |
| 2024-09-30 | 2.86 |
| 2024-06-30 | 2.61 |
| 2024-03-31 | 3.26 |
| 2023-12-31 | 2.62 |
| 2023-09-30 | 3.51 |
| 2023-06-30 | 3.43 |
| 2023-03-31 | 3.71 |
| 2022-12-31 | 3.32 |
| 2022-09-30 | 3.99 |
| 2022-06-30 | 3.51 |
| 2022-03-31 | 3.37 |
| 2021-12-31 | 2.98 |
| 2021-09-30 | 7.25 |
| 2021-06-30 | 5.82 |
| 2021-03-31 | 5.48 |
| 2020-12-31 | 4.60 |
| 2020-09-30 | 1.54 |
| 2020-06-30 | 2.13 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.39 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
